By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antianginal agents > Minitran (transdermal) > Minitran Prescribing Information
Antianginal agents
https://themeditary.com/pro/minitran-prescribing-information-13823.html

Minitran Prescribing Information

Drug Detail:Minitran (transdermal) (Nitroglycerin (transdermal) [ nye-troe-glis-er-in ])

Drug Class: Antianginal agents Vasodilators

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

MINITRAN™ 5 mg (Italy)

MINITRAN™ 5 mg/24 ore

Cerotti transdermici

AIC n. 027028012

Nitroglicerina

15 cerotti transdermici

superficia di rilascio:

6,7 cm2

MEDA

Italy-5mg

VENITRAN™ 5 mg (Italy)

VENITRAN™ 5MG/24HR

Nitroglycerin

B33211

31-0053-3211-4 / 7100088129

Lot HIJ123K

Exp. 12-2017

Meda-Venitran-Italy-5mg

MINITRAN™ 5 mg (Switzerland)

MINITRAN™ 5

Nitroglycerin

B33233

31-0053-3233-8

Lot III555J

Exp. 12.2018

MEDA

Meda-Swiss-5mg

Related/similar drugs

amlodipine, lisinopril, metoprolol, losartan, aspirin, furosemide, carvedilol

MINITRAN™ 5 mg (Belgium)

MINITRAN™ 5 mg

Nitroglycerine 18 mg/pleister

Nitroglycérine 18 mg/dispositif

Nitroglycerin 18 mg/pflaster

30 Pleisters voor transdermaal gebruik

30 Dispositifs transdermiques

30 Transdermale Pflaster

Elke pleister geeft 0,2 mg nitroglycerine af per uur,

overeenkomend met 5 mg per 24 uur.

Chaque dispositif délivre 0,23 mg de nitroglycérine

par heure, équivalent à 5 mg/24 h.

Jedes Pflaster setzt 0,2 mg Nitroglycerin pro

Stunde frei, entsprechend 5 mg in 24 Stunden.

MYLAN

Minitran-Belgium-5mg

MINITRAN™ 5 mg (Mexico)

MINITRAN™

Trinitrato de glicerilo

31-0053-3204-9

Lote: 999991A

Cad: MAR18

Reg. No. 074M91 SSA IV

Parche 18 mg

Cada parche libera 0.2 mg por hora. 5 mg/24 horas

Hecho en EUA por:

3M Drug Delivery Systems

Northridge CA, 91324, EUA

Importado y Distribuido por:

More Pharma Corporation S. de R.L. de C.V.

Blvd. Adolfo Lopez Mateos No. 314 PB, Col.

Tiacopac, C.P. 01049

Deleg. Alvaro Obregón

Ciudad de México, México

More Pharma

Pharmaceutical Company

Consérvese a temperatura ambiente a no mas de

30ºC y en lugar seco.

Quantity 5760

Minitran-Mexico-5mg

MINITRAN™ 10 mg (Italy)

MINITRAN™ 10 mg/24 ore

Cerotti transdermici

AIC n. 027028024

Nitroglicerina

15 cerotti transdermici

Superficie di rilascio:

13,3 cm 2

MEDA

Italy-10mg

VENITRAN™ 10 mg (Italy)

VENITRAN™ 10MG/24HR

Nitroglycerin

B33333

31-0053-3333-6

Lot KKK666L

Exp. 12.2018

MEDA

Meda-Venitran-Italy-10mg

MINITRAN® 10 mg (Belgium)

MINITRAN® 10 mg

Nitroglycerine 36 mg/pleister

Nitroglycérine 36 mg/dispositif

Nitroglycerin 36 mg/pflaster

30 Pleisters voor transdermaal gebruik

30 Dispositifs transdermiques

30 Transdermale Pflaster

Elke pleister geeft 0,4 mg nitroglycerine af per uur,

overeenkomend met 10 mg per 24 uur.

Chaque dispositif délivre 0,4 mg de nitroglycérine

par heure, équivalent à 10mg/24 h.

Jedes Pflaster setzt 0,4 mg Nitroglycerin pro

Stunde frei, entsprechend 10 mg in 24 Stunden.

MYLAN

Minitran-Belgium-10

MINITRAN™ 10 (Switzerland)

MINITRAN™ 10MG/24HR

Nitroglycerin

B33333

31-0053-3333-6

Lot KKK666L

Exp. 12.2018

MEDA

Meda-Swiss-10mg

MINITRAN™ 15 mg (Italy)

MINITRAN™ 15 mg/24 ore

Cerotti transdermici

AIC n. 027028036

Nitroglicerina

15 cerotti transdermici

Superficie di rilascio: 20 cm 2

MEDA

Italy-15mg

VENITRAN™ 15 mg (Italy)

VENITRAN™ 15MG/24HR

Nitroglycerin

B33411

31-0053-3411-0 / 7100088860

Lot LMN4560

Exp. 12-2018

MEDA

Meda-Venitran-Italy-15mg

MINITRAN™ 15 mg (Belgium)

MINITRAN™ 15 mg

Nitroglycerine 54 mg/pleister

Nitroglycérine 54 mg/dispositif

Nitroglycerin 54 mg/pflaster

30 Pleisters voor transdermaal gebruik

30 Dispositifs transdermiques

30 Transdermale Pflaster

Elke pleister geeft 0,6 mg nitroglycerine af per uur,

overeenkomend met 15 mg per 24 uur.

Chaque dispositif délivre 0,6 mg de nitroglycérine

par heure, équivalent à 15 mg/24 h.

Jedes Pflaster setzt 0,6 mg Nitroglycerin pro

Stunde frei, entsprechend 15 mg in 24 Stunden.

MYLAN

Minitran-Belgiium-15

MINITRAN™ 10 mg (Mexico)

MINITRAN™

Trinitrato de Glicerilo

Parche

36 mg

Cada Parche Libera 0.4 mg por hora

10 mg/24 horas

Lote/Lot: XXXXXX

Cad./Exp.: YYYXX

5760

Consérvese a temperatura

ambiente a no más de

30° yen en lugar seco.

Reg. No. 074M91 SSA IV

T M: Marca Registrada/Registered Trademark

More Pharma

Pharmaceutical Company

31-0053-3304-7

Distribuido Por:

More Pharma Corporation S. De R.L.. De C.V.

Av. Ejército Nacional No. 926

Col. Los morales, Seccion Palmas

C.P. 11540, Dele. Miguel Hidalgo,

D.F., México.

Hecho en E.U.A Por:

3M Drug Delivery Systems,

Northridge, Ca 91324 EUA

Minitran-10mg-Mexico

MINITRAN
nitroglycerin patch
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0089-0171
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) NITROGLYCERIN18 mg
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0089-0171-0230 in 1 CARTON; Type 0: Not a Combination Product02/21/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Export only02/21/2012
MINITRAN
nitroglycerin patch
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0089-0172
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) NITROGLYCERIN36 mg
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0089-0172-0230 in 1 CARTON; Type 0: Not a Combination Product02/21/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Export only02/21/2012
MINITRAN
nitroglycerin patch
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0089-0173
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) NITROGLYCERIN54 mg
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0089-0173-0230 in 1 CARTON; Type 0: Not a Combination Product02/21/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Export only02/21/2012
Labeler - Kindeva Drug Delivery L.P. (117492677)
Establishment
NameAddressID/FEIBusiness Operations
Kindeva Drug Delivery L.P.128688199manufacture(0089-0171, 0089-0172, 0089-0173)

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by